Literature DB >> 18682497

Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator.

Xiu-Bao Chang1, April Mengos, Yue-Xian Hou, Liying Cui, Timothy J Jensen, Andrei Aleksandrov, John R Riordan, Martina Gentzsch.   

Abstract

The epithelial chloride channel CFTR is a glycoprotein that is modified by two N-linked oligosaccharides. The most common mutant CFTR protein in patients with cystic fibrosis, DeltaF508, is misfolded and retained by ER quality control. As oligosaccharide moieties of glycoproteins are known to mediate interactions with ER lectin chaperones, we investigated the role of N-linked glycosylation in the processing of wild-type and DeltaF508 CFTR. We found that N-glycosylation and ER lectin interactions are not major determinants of trafficking of wild-type and DeltaF508 from the ER to the plasma membrane. Unglycosylated CFTR, generated by removal of glycosylation sites or treatment of cells with the N-glycosylation inhibitor tunicamycin, did not bind calnexin, but did traffic to the cell surface and exhibited chloride channel activity. Most importantly, unglycosylated DeltaF508 CFTR still could not escape quality control in the early secretory pathway and remained associated with the ER. However, the absence of N-linked oligosaccharides did reduce the stability of wild-type CFTR, causing significantly more-rapid turnover in post-ER compartments. Surprisingly, the individual N-linked carbohydrates do not play equivalent roles and modulate the fate of the wild-type protein in different ways in its early biosynthetic pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682497      PMCID: PMC2677381          DOI: 10.1242/jcs.028951

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  87 in total

1.  Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.

Authors:  Xiaodong Wang; John Venable; Paul LaPointe; Darren M Hutt; Atanas V Koulov; Judith Coppinger; Cemal Gurkan; Wendy Kellner; Jeanne Matteson; Helen Plutner; John R Riordan; Jeffery W Kelly; John R Yates; William E Balch
Journal:  Cell       Date:  2006-11-17       Impact factor: 41.582

Review 2.  The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function.

Authors:  Christian Appenzeller-Herzog; Hans-Peter Hauri
Journal:  J Cell Sci       Date:  2006-06-01       Impact factor: 5.285

Review 3.  Molecular targeting of CFTR as a therapeutic approach to cystic fibrosis.

Authors:  Margarida D Amaral; Karl Kunzelmann
Journal:  Trends Pharmacol Sci       Date:  2007-06-18       Impact factor: 14.819

Review 4.  Polarized membrane distribution of potassium-dependent ion pumps in epithelial cells: different roles of the N-glycans of their beta subunits.

Authors:  Olga Vagin; Shahlo Turdikulova; Elmira Tokhtaeva
Journal:  Cell Biochem Biophys       Date:  2007       Impact factor: 2.194

5.  Calnexin regulated gonadotropin-releasing hormone receptor plasma membrane expression.

Authors:  Shaun P Brothers; Jo Ann Janovick; P Michael Conn
Journal:  J Mol Endocrinol       Date:  2006-12       Impact factor: 5.098

6.  Curcumin enhances cystic fibrosis transmembrane regulator expression by down-regulating calreticulin.

Authors:  Kazutsune Harada; Tsukasa Okiyoneda; Yasuaki Hashimoto; Kimiko Oyokawa; Kimitoshi Nakamura; Mary Ann Suico; Tsuyoshi Shuto; Hirofumi Kai
Journal:  Biochem Biophys Res Commun       Date:  2006-12-13       Impact factor: 3.575

7.  Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator.

Authors:  J Michael Younger; Liling Chen; Hong-Yu Ren; Meredith F N Rosser; Emma L Turnbull; Chun-Yang Fan; Cam Patterson; Douglas M Cyr
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

8.  Rescue of DeltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules.

Authors:  Fredrick Van Goor; Kimberly S Straley; Dong Cao; Jesús González; Sabine Hadida; Anna Hazlewood; John Joubran; Tom Knapp; Lewis R Makings; Mark Miller; Timothy Neuberger; Eric Olson; Victor Panchenko; James Rader; Ashvani Singh; Jeffrey H Stack; Roger Tung; Peter D J Grootenhuis; Paul Negulescu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-01-27       Impact factor: 5.464

9.  The MRH protein Erlectin is a member of the endoplasmic reticulum synexpression group and functions in N-glycan recognition.

Authors:  Cristina-Maria Cruciat; Christine Hassler; Christof Niehrs
Journal:  J Biol Chem       Date:  2006-03-10       Impact factor: 5.157

Review 10.  Rescue of folding defects in ABC transporters using pharmacological chaperones.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

View more
  41 in total

1.  Cell surface rescue of kidney anion exchanger 1 mutants by disruption of chaperone interactions.

Authors:  Sian T Patterson; Reinhart A F Reithmeier
Journal:  J Biol Chem       Date:  2010-07-13       Impact factor: 5.157

2.  Characterization of Δ(G970-T1122)-CFTR, the most frequent CFTR mutant identified in Japanese cystic fibrosis patients.

Authors:  Kanako Wakabayashi-Nakao; Yingchun Yu; Miyuki Nakakuki; Tzyh-Chang Hwang; Hiroshi Ishiguro; Yoshiro Sohma
Journal:  J Physiol Sci       Date:  2018-06-27       Impact factor: 2.781

3.  Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures.

Authors:  Deborah M Cholon; Wanda K O'Neal; Scott H Randell; John R Riordan; Martina Gentzsch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-12-11       Impact factor: 5.464

4.  Constitutive internalization of the leucine-rich G protein-coupled receptor-5 (LGR5) to the trans-Golgi network.

Authors:  Joshua C Snyder; Lauren K Rochelle; H Kim Lyerly; Marc G Caron; Lawrence S Barak
Journal:  J Biol Chem       Date:  2013-02-25       Impact factor: 5.157

5.  Restoration of R117H CFTR folding and function in human airway cells through combination treatment with VX-809 and VX-770.

Authors:  Martina Gentzsch; Hong Y Ren; Scott A Houck; Nancy L Quinney; Deborah M Cholon; Pattarawut Sopha; Imron G Chaudhry; Jhuma Das; Nikolay V Dokholyan; Scott H Randell; Douglas M Cyr
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-07-08       Impact factor: 5.464

6.  FK506 binding protein 8 peptidylprolyl isomerase activity manages a late stage of cystic fibrosis transmembrane conductance regulator (CFTR) folding and stability.

Authors:  Darren M Hutt; Daniela Martino Roth; Monica A Chalfant; Robert T Youker; Jeanne Matteson; Jeffrey L Brodsky; William E Balch
Journal:  J Biol Chem       Date:  2012-04-02       Impact factor: 5.157

7.  A survey of detergents for the purification of stable, active human cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Ellen Hildebrandt; Qinghai Zhang; Natasha Cant; Haitao Ding; Qun Dai; Lingling Peng; Yu Fu; Lawrence J DeLucas; Robert Ford; John C Kappes; Ina L Urbatsch
Journal:  Biochim Biophys Acta       Date:  2014-07-24

8.  Impaired glycosylation blocks DPP10 cell surface expression and alters the electrophysiology of Ito channel complex.

Authors:  Diego Cotella; Susanne Radicke; Alessio Bortoluzzi; Ursula Ravens; Erich Wettwer; Claudio Santoro; Daniele Sblattero
Journal:  Pflugers Arch       Date:  2010-03-31       Impact factor: 3.657

Review 9.  From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking.

Authors:  Carlos M Farinha; Sara Canato
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

10.  N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic.

Authors:  Rina Glozman; Tsukasa Okiyoneda; Cory M Mulvihill; James M Rini; Herve Barriere; Gergely L Lukacs
Journal:  J Cell Biol       Date:  2009-03-23       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.